CVS Health Corporation a U.S. based Company, belongs to Healthcare sector and Health Care Plans industry. The firm now has a hold rating on the pharmacy operator's stock.
Have you taken a look at the chart for CVS Health Corporation (NYSE:CVS) lately?
A number of institutional investors and hedge funds have recently added to or reduced their stakes in CVS. The Btc Capital Management Inc holds 96,889 shares with $7.80 million value, up from 83,903 last quarter. Springbok Capital Management LLC now owns 1,130 shares of the pharmacy operator's stock worth $117,000 after buying an additional 741 shares during the last quarter.
Techniacal Analysis: The company has the market capitalization of $74.52B. Insiders sold 716,625 shares of company stock valued at $58,318,431 in the last ninety days. Fieldpoint Private Securities LLC raised its stake in CVS Health Corporation by 333.3% during the second quarter. Elefante Mark B now owns 6,400 shares of the pharmacy operator's stock worth $515,000 after buying an additional 45 shares in the last quarter. Finally, British Columbia Investment Management Corp grew its position in shares of CVS Health Corporation by 3.7% in the first quarter. Accern also gave headlines about the pharmacy operator an impact score of 45.5851763176181 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days. Community Bank N.A. grew its position in shares of CVS Health Corporation by 7.3% in the second quarter. The fund owned 45,842 shares of the pharmacy operator's stock after selling 15,760 shares during the period. The stock was sold at an average price of $81.17, for a total transaction of $1,667,799.99. The stock closed the regular trading session at $68.99 yesterday, compared to the closing price of $73.31 the previous day - a change of -5.89 percent. At the moment, CVS has 1.08 shares outstanding.
U.S. based company CVS Health Corporation (CVS)'s latest closing price was -12.54% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at -11.70% and -9.30% compared with the 20 Day Moving Average. The third largest holder is State Street Corp, which now holds $3.02 billion worth of this stock and that ownership represents almost 4.05% of its market capitalization. The company rocked its 52-Week High of $84.89 and touched its 52-Week Low of $68.16. The pharmacy operator reported $1.33 earnings per share for the quarter, beating analysts' consensus estimates of $1.31 by $0.02. The Return on Assets for CVS Health Corporation (NYSE:CVS) is 0.056928. Sky Investment Grp Inc Ltd Company reported 15,393 shares stake. During the same quarter in the prior year, the company posted $1.32 earnings per share. For the current quarter, the average analyst estimate for net revenue is $46.17 billion - compared to 44.62 billion in the year-ago quarter.
The company also recently declared a quarterly dividend, which will be paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, October 23rd. This represents a $2.00 annualized dividend and a yield of 2.90%. CVS Health Corporation's payout ratio is 39.92%. "Trims Holdings in CVS Health Corporation (CVS)" was published by TrueBlueTribune and is owned by of TrueBlueTribune. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and global copyright & trademark legislation. The correct version of this news story can be accessed at https://www.truebluetribune.com/2017/10/30/montag-a-associates-inc-trims-holdings-in-cvs-health-corporation-cvs.html. Legg Mason Asset Management Japan acquired 22,000 shares as Qualcomm Inc (QCOM)'s stock rose 2.14%. The shares were sold at an average price of $79.65, for a total transaction of $18,883,262.70. After this sale, 60,361 common shares of CVS are directly owned by the insider, with total stake valued at $4,164,305. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The insider Denton David M sold $18.44M. Following the completion of the sale, the insider now owns 299,255 shares in the company, valued at $24,859,112.85. The disclosure for this sale can be found here.
A number of analysts have commented on CVS shares. Finally, Wolfe Research lowered shares of CVS Health Corporation from an "outperform" rating to a "market perform" rating and reduced their target price for the company from $89.00 to $82.00 in a report on Monday, August 14th. Jefferies Group LLC set a $86.00 target price on shares of CVS Health Corporation and gave the company a "hold" rating in a report on Wednesday, October 18th. Oppenheimer Holdings, Inc. restated a buy rating and set a $95.00 target price on shares of CVS Health Corporation in a report on Monday, October 9th. Robert W. Baird reissued a "hold" rating and issued a $77.00 price target on shares of CVS Health Corporation in a report on Friday. S&P Research maintained the stock with "Strong Buy" rating in Monday, November 2 report. Canaccord Genuity maintained the shares of QCOM in report on Wednesday, October 12 with "Buy" rating.
- Corey Feldman Defends Not Naming Alleged Hollywood Pedophiles
- Destiny 2 Adds the 'Curse of Osiris' Expansion in December
- Rains lash several parts of Tamil Nadu, one killed in wall collapse
- Defying US, Rouhani vows continued missile development
- Zlatan Ibrahimovic sends title warning to Manchester City
- Google Pixel 2, Pixel 2 XL issues
- Chance The Rapper Will Host Saturday Night Live Next Month
- SoftBank to halt Sprint's T-Mobile merger talks, Nikkei says
- Selena Gomez and Francia Raísa Share Kidney Transplant Story in Emotional Interview
- Heathrow to probe leak of security files